The chromosome 9p21 risk locus is associated with angiographic severity and progression of coronary artery disease

• Published in: European heart journal 2010-12, Vol.31 (24), p.3017-3023
• Main Authors: Patel, Riyaz S., Su, Shaoyong, Neeland, Ian J., Ahuja, Ayushi, Veledar, Emir, Zhao, Jinying, Helgadottir, Anna, Holm, Hilma, Gulcher, Jeffrey R., Stefansson, Kari, Waddy, Salina, Vaccarino, Viola, Zafari, A. Maziar, Quyyumi, Arshed A.
• Format: Article
• Language: English
• Subjects: 9p21; Adult; Aged; Aged, 80 and over; angiography; Atherosclerosis; Atherosclerosis (general aspects, experimental research); Biological and medical sciences; Blood and lymphatic vessels; Cardiology. Vascular system; Cardiovascular system; Chromosomes, Human, Pair 9 - genetics; Clinical Research; Coronary Angiography; Coronary Artery Disease - diagnostic imaging; Coronary Artery Disease - genetics; coronary disease; Coronary heart disease; Disease Progression; Female; Genetic Markers - genetics; Genetic Predisposition to Disease - genetics; genetics; genomics; Genotype; Heart; Homozygote; Humans; Investigative techniques, diagnostic techniques (general aspects); Male; Medical sciences; Middle Aged; Myocardial Infarction - diagnostic imaging; Myocardial Infarction - genetics; Polymorphism, Single Nucleotide - genetics; Radiodiagnosis. Nmr imagery. Nmr spectrometry; Risk Factors; Young Adult
• ISSN: 0195-668X; 1522-9645
• DOI: 10.1093/eurheartj/ehq272

Aims We tested the hypothesis that the 9p21 risk locus promotes atherosclerosis by examining the association between rs10757278 and coronary artery disease (CAD) severity and progression determined by semi-quantitative angiographic scores. Methods and results The rs10757278 single nucleotide polymorphism (SNP) was genotyped as the marker for the 9p21 locus in 2334 Caucasian patients undergoing cardiac catheterization (mean age 63, male 67%). Angiographic CAD was assessed using two semi-quantitative scoring systems with one estimating severity (Gensini) and the other extent (Sullivan). A subset of 308 patients who underwent two or more coronary angiograms at least 6 months apart were examined for net change in Gensini and Sullivan scores over time to determine the rate of CAD progression by genotype and were further classified as ‘progressors’ or ‘non-progressors’ based on absolute change per year in angiographic severity score. We replicated the association between the rs10757278 SNP and myocardial infarction and binary (presence/absence) angiographic classifications of CAD. Furthermore, we observed a significant additive association with this SNP, and both severity and extent of CAD using angiographic scores, after adjustment for age, gender, body mass index, traditional cardiovascular risk factors, myocardial infarction, and statin use (Gensini P = 0.016, Sullivan P = 0.005). In addition, there was a significant linear association with CAD progression before and after adjustment for covariates (Gensini P = 0.023, Sullivan P = 0.003) with homozygotes for the risk variant having three-fold greater odds of CAD progression compared with the referent group. Conclusion The 9p21 risk locus is associated with angiographically defined severity, extent, and progression of CAD, suggesting a role for this locus in influencing atherosclerosis and its progression.